Vir Biotechnology Inc (VIR)
7.63
-0.41
(-5.10%)
USD |
NASDAQ |
Apr 25, 16:00
7.60
-0.03
(-0.39%)
After-Hours: 20:00
Vir Biotechnology Shareholders Equity (Quarterly): 1.590B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.590B |
| September 30, 2023 | 1.675B |
| June 30, 2023 | 1.810B |
| March 31, 2023 | 1.971B |
| December 31, 2022 | 2.078B |
| September 30, 2022 | 2.150B |
| June 30, 2022 | 1.952B |
| March 31, 2022 | 2.001B |
| December 31, 2021 | 1.432B |
| September 30, 2021 | 876.27M |
| Date | Value |
|---|---|
| June 30, 2021 | 737.32M |
| March 31, 2021 | 650.95M |
| December 31, 2020 | 716.85M |
| September 30, 2020 | 812.36M |
| June 30, 2020 | 563.78M |
| March 31, 2020 | 380.33M |
| December 31, 2019 | 423.94M |
| September 30, 2019 | -280.80M |
| June 30, 2019 | 401.45M |
| December 31, 2018 | -179.18M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-280.80M
Minimum
Sep 2019
2.150B
Maximum
Sep 2022
1.155B
Average
876.27M
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 17.58B |
| Vistagen Therapeutics Inc | 123.28M |
| Immuneering Corp | 90.58M |
| SeaStar Medical Holding Corp | -13.87M |
| NovaBay Pharmaceuticals Inc | 3.314M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.919B |
| Total Liabilities (Quarterly) | 328.82M |
| Current Ratio | 9.054 |